These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 17612951)

  • 1. Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach.
    Bokkers BG; Slob W
    Crit Rev Toxicol; 2007 Jun; 37(5):355-73. PubMed ID: 17612951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of ratio distributions based on the NOAEL and the benchmark approach for subchronic-to-chronic extrapolation.
    Bokkers BG; Slob W
    Toxicol Sci; 2005 Jun; 85(2):1033-40. PubMed ID: 15772368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration.
    Willhite CC; Ball GL; McLellan CJ
    J Toxicol Environ Health B Crit Rev; 2008 Feb; 11(2):69-146. PubMed ID: 18188738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
    Zhu Y; Wang T; Jelsovsky JZ
    Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allometric principles for interspecies extrapolation in toxicological risk assessment--empirical investigations.
    Schneider K; Oltmanns J; Hassauer M
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):334-47. PubMed ID: 15135212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
    Kirman CR; Sweeney LM; Corley R; Gargas ML
    Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A procedure for developing risk-based reference doses.
    Gaylor DW; Kodell RL
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):137-41. PubMed ID: 12051999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interspecies extrapolation based on the RepDose database--a probabilistic approach.
    Escher SE; Batke M; Hoffmann-Doerr S; Messinger H; Mangelsdorf I
    Toxicol Lett; 2013 Apr; 218(2):159-65. PubMed ID: 23395978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
    Filipsson AF; Sand S; Nilsson J; Victorin K
    Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the uncertainty factor for subchronic-to-chronic extrapolation: statistical analysis of toxicity data.
    Pieters MN; Kramer HJ; Slob W
    Regul Toxicol Pharmacol; 1998 Apr; 27(2):108-11. PubMed ID: 9671565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Background to the ADI/TDI/PTWI.
    Herrman JL; Younes M
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S109-13. PubMed ID: 10597623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicology and human health assessment of decabromodiphenyl ether.
    Hardy ML; Banasik M; Stedeford T
    Crit Rev Toxicol; 2009 Nov; 39 Suppl 3():1-44. PubMed ID: 19874087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an occupational exposure limit for n-propylbromide using benchmark dose methods.
    Stelljes ME; Wood RR
    Regul Toxicol Pharmacol; 2004 Oct; 40(2):136-50. PubMed ID: 15450717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current state of knowledge on the use of the benchmark dose concept in risk assessment.
    Sand S; Victorin K; Filipsson AF
    J Appl Toxicol; 2008 May; 28(4):405-21. PubMed ID: 17879232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interspecies scaling and comparisons in drug development and toxicokinetics.
    Ings RM
    Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health assessment of phosgene: approaches for derivation of reference concentration.
    Gift JS; McGaughy R; Singh DV; Sonawane B
    Regul Toxicol Pharmacol; 2008 Jun; 51(1):98-107. PubMed ID: 18440110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of myocardial and testicular end points as a basis for estimating a proposed tolerable daily intake for sodium monofluoroacetate (1080).
    Foronda NM; Fowles J; Smith N; Taylor M; Temple W; Darlington C
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):29-36. PubMed ID: 17030370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the benchmark dose for point of departure determination for a variety of chemical classes in applied regulatory settings.
    Izadi H; Grundy JE; Bose R
    Risk Anal; 2012 May; 32(5):830-5. PubMed ID: 22126138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans.
    Dorne JL; Renwick AG
    Toxicol Sci; 2005 Jul; 86(1):20-6. PubMed ID: 15800035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.